News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Over 300 Italian schools evacuated after hoax bomb emails; similar alerts disrupted schools in the UK and Ireland.
  • Germany's economic council raised growth forecasts to about 1% on stronger exports and government spending.
  • Talen Energy stock jumped after a seven-year sale of 750 MW capacity, adding roughly $100m annual capacity revenue and boosting contracted margin visibility.
  • Brazil's electoral court fined Meta 7.5 million reais for compliance lapses but found no evidence of intentional election bias.
  • Google, Meta and TikTok told Indonesian legislators they oppose proposed copyright and AI rules requiring news payments and new AI controls.
  • Analysts upgraded The Hartford to buy, citing investment yield and capital returns, targeting $155 with a $128 stop.
  • Western Digital recommended as a strong buy on higher-capacity HDD demand, improving margins and free cash flow for AI-storage exposure.

Latest Articles

AVITA Medical to Participate in Lake Street Best Ideas Growth Conference and Morgan Stanley Healthcare Conference

AVITA Medical to Participate in Lake Street Best Ideas Growth Conference and Morgan Stanley Healthcare Conference

AVITA Medical, a therapeutic acute wound care company, announced that its senior management will participate in the Lake Street Best Ideas Growth Conference and the Morgan Stanley Global Healthcare Conference, presenting their innovative wound healing technologies, including FDA-approved RECELL and other biosynthetic wound matrices. Investor meetin…

Nyxoah Announces ACCCESS U.S. Pivotal Study Meets Primary Safety and Efficacy Endpoints in Complete Concentric Collapse Patients

Nyxoah Announces ACCCESS U.S. Pivotal Study Meets Primary Safety and Efficacy Endpoints in Complete Concentric Collapse Patients

Nyxoah announced that its ACCCESS U.S. pivotal study for the Genio system successfully met primary safety and efficacy endpoints in patients with Complete Concentric Collapse (CCC) obstructive sleep apnea (OSA). The study reported a 77.2% Apnea-Hypopnea Index (AHI) responder rate and zero device-related serious adverse events over 12 months. The re…

Gold.com Reports Fiscal Fourth Quarter and Full Year 2026 Results

Gold.com Reports Fiscal Fourth Quarter and Full Year 2026 Results

Gold.com, a leading integrated alternative assets platform specializing in precious metals and collectibles, reported robust fiscal fourth quarter and full year 2026 financial results. The company achieved significant revenue growth driven by organic expansion, strategic acquisitions including Sunshine Minting, and increased sales volume. Net incom…

Amwell® to participate in upcoming investor conferences

Amwell® to participate in upcoming investor conferences

Amwell (NYSE: AMWL), a leader in technology-enabled healthcare platforms, announced that its CFO and COO Mark Hirschhorn will represent the company at two prestigious investor conferences in September 2026. These events include the Wells Fargo 21st Annual Healthcare Conference and the Morgan Stanley 24th Annual Global Healthcare Conference, where t…

Appian CFO to Present at Citi’s Global TMT Conference

Appian CFO to Present at Citi’s Global TMT Conference

Appian announced that its CFO, Serge Tanjga, will present at Citi's Global TMT Conference in New York, delivering a live webcasted fireside chat focusing on the company's AI automation platform for enterprise business processes. The presentation highlights Appian's ongoing commitment to AI-powered process automation for large organizations.

Elutia to Participate in the Lake Street Capital Markets 10th Annual Big Ideas Growth Conference & the H.C. Wainwright 28th Annual Global Investment Conference

Elutia to Participate in the Lake Street Capital Markets 10th Annual Big Ideas Growth Conference & the H.C. Wainwright 28th Annual Global Investment Conference

Elutia Inc., a Nasdaq-listed company specializing in drug-eluting biomatrix technologies, announced its participation in the Lake Street Capital Markets 10th Annual Big Ideas Growth Conference and the H.C. Wainwright 28th Annual Global Investment Conference. The company’s leadership will present their technology developments focused on addressing p…

SOLOWIN HOLDINGS (AXG)’s AlloyX HK and EvolveQ Signed Strategic MOU to Integrate AI and Quantum Computing for Next-Generation Financial Infrastructure

SOLOWIN HOLDINGS (AXG)’s AlloyX HK and EvolveQ Signed Strategic MOU to Integrate AI and Quantum Computing for Next-Generation Financial Infrastructure

SOLOWIN HOLDINGS (Nasdaq: AXG) announced that its subsidiary AlloyX HK has signed a strategic non-binding MOU with EvolveQ to explore the integration of AI, quantum computing, and high-performance computing in finance and digital assets. The collaboration aims to develop next-generation AI wealth management platforms, enhance AI infrastructure, and…

Surrozen to Present at Upcoming Healthcare Investor Conferences

Surrozen to Present at Upcoming Healthcare Investor Conferences

Surrozen, Inc., a Nasdaq-listed biotechnology company focused on Wnt signaling therapeutics for sight-threatening ophthalmic diseases, announced that its management will present at the 2026 Cantor Global Healthcare and Morgan Stanley Global Healthcare conferences. The company provided updates on its development plans including initiating a Phase 1b…

Option Care Health to Participate in Upcoming Investor Conferences

Option Care Health to Participate in Upcoming Investor Conferences

Option Care Health, the largest independent provider of home and alternate site infusion services in the U.S., announced that its CEO and CFO will present at the Morgan Stanley Global Healthcare Conference and Deutsche Bank Healthcare Summit in September 2026. The company aims to share its business outlook and strategies with investors during these…

Ultragenyx Announces Phase 3 Aspire results in Angelman Syndrome

Ultragenyx Announces Phase 3 Aspire results in Angelman Syndrome

Ultragenyx Pharmaceutical announced that its Phase 3 Aspire clinical trial of apazunersen (GTX-102) for Angelman syndrome did not meet the primary or key secondary efficacy endpoints. Despite a consistent safety profile, the company expressed disappointment and will evaluate the future of the program while planning to implement significant expense …

Duolingo to Participate in Citi’s 2026 Global TMT Conference

Duolingo to Participate in Citi’s 2026 Global TMT Conference

Duolingo announced that CEO Luis von Ahn will participate in a fireside chat at the Citi 2026 Global TMT Conference. The event will be webcast live and later available for replay. Duolingo is recognized as the leading mobile language learning platform globally, known for its highly popular app and commitment to quality and accessibility in educatio…

Black Diamond Therapeutics to Participate in H.C. Wainwright 28th Annual Global Investment Conference

Black Diamond Therapeutics to Participate in H.C. Wainwright 28th Annual Global Investment Conference

Black Diamond Therapeutics announced its participation in the H.C. Wainwright 28th Annual Global Investment Conference, with a presentation and one-on-one investor meetings scheduled. The company highlighted advancements in its investigational EGFR inhibitor, silevertinib, targeting oncology indications such as EGFR-mutant non-small cell lung cance…

Aura Biosciences to Participate in Upcoming Investor Conference

Aura Biosciences to Participate in Upcoming Investor Conference

Aura Biosciences, a clinical-stage biotechnology company focused on developing a novel therapy for ocular cancers, announced its CEO, Natalie Holles, will participate in the Morgan Stanley 24th Annual Global Healthcare Conference. The company highlighted its Phase 3 fully enrolled trial for bel-sar in early choroidal melanoma and ongoing studies in…